There are several market and technology drivers impacting on precision medicine including an ageing population, increasing healthcare costs and the emergence of new disruptive technologies. Advances in technology are accelerating a shift in healthcare from reaction to prevention and early stage treatments and the global precision medicine market was estimated at almost $43bn in 2016 and is projected to rise to around $134bn by 2025.

Scotland’s ecosystem for precision medicine includes a strong network of universities, research institutions, NHS facilities, enterprise and skills agencies and industry bodies all focussed on developing, commercialising and implementing our world-class research in precision medicine. Scotland has a growing number of businesses involved in precision medicine, including new start-ups and in-movers involved in developing digital platforms for health data, informatics, AI and machine learning.

Click here to read the special report on this event

Our 2019 supporting partners: